Rockwell Medical is a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia. Rockwell Medical's vision is to establish a new standard of care in iron deficiency and anemia management, which is built on our novel and differentiated core technology platform, Ferric Pyrophosphate Citrate (FPC).

For more information, visit www.RockwellMed.com and follow us on www.twitter.com/rockwellmedical or www.linkedin.com/company/rockwell-medical/. 

For more educational material on iron management in adult patients with HDD-CKD, please visit www.restoringironessentials.com.